91 results on '"Pardi, Darrell S."'
Search Results
2. S77 Safety and Efficacy of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Older Patients With Recurrent Clostridioides difficile Infection: Findings From an Integrated Analysis of Phase 3 Trials
3. S244 Open Label Experience With Bismuth Subsalicylate in Patients With Microscopic Colitis
4. S753 Clinical, Endoscopic and Histologic Features of Common Variable Immunodeficiency
5. S207 Predictive Machine Learning Models for Recurrent C. difficile Infection in Inflammatory Bowel Disease Patients Based on First-Episode CDI Treatment
6. S2404 Clinical Manifestations of Sclerosing Mesenteritis: A Case Series
7. S233 Clinical Outcomes and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis
8. S208 A Machine Learning Model for Predicting Recurrent C. difficile Infection in Patients With Inflammatory Bowel Disease (Recur CDI-IBD)
9. S206 Predicting Recurrent C. difficile Infection in IBD Patients: An Application of AutoML Tabular and Text Classification Models on Electronic Health Records and Clinical Notes
10. S3329 Delayed Acute Pancreatitis After Transpapillary Gallbladder Drainage With Plastic Stents, A Case Series
11. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis
12. S133 An Open-Label Study (ECOSPOR IV) to Evaluate the Safety, Efficacy and Durability of SER-109, an Investigational Oral Microbiome Therapeutic, in Adults With Recurrent Clostridioides difficile Infection (rCDI)
13. S889 Use of Newer Biologic Therapies in Patients With Refractory Microscopic Colitis
14. S996 Chasing the Common Variable Immunodeficiency Zebra: Endoscopic/Histopathologic Findings and Treatment
15. S197 Real Word Experience of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-analysis
16. S194 Real World Experience of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Mayo Clinic Experience
17. S177 Reduction in Urinary Tract Infections in Patients Treated With Fecal Microbiota Transplantation for Recurrent C. difficile Infection: A Case Control Study
18. S2168 The Use of Rituximab for IgG4–Related Sclerosing Mesenteritis
19. S135 Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing
20. S830 Fidaxomicin for Treatment of Clostridioides difficile Infection in Patients With Inflammatory Bowel Disease
21. Management of Acute and Chronic Pouchitis
22. Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile From a Population-Based Study
23. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease
24. Vulvar Crohn's Disease: Clinical Features and Outcomes
25. Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows
26. S0193 Outcomes of Pediatric Hospital and Community-Associated Clostridioides difficile Infection
27. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
28. Clostridium difficile Infection in the Emergency Department
29. Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection
30. Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection
31. Case report
32. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
33. Clostridium difficile Infection in Inflammatory Bowel Disease Patients: Influence of Antibiotic Choice on Adverse Outcomes
34. Pentoxifylline Use in Microscopic Colitis: A Case Series
35. Statins May Decrease the Risk of Clostridium difficile Infection: A Systematic Review and Meta-Analysis
36. The Role of Anti-Tumor Necrosis Factor Therapy in Microscopic Colitis
37. Outcomes of Bismuth Subsalicylate Treatment in Patients With Microscopic Colitis
38. Low Resolution rates in Open-Label and Randomized Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
39. Predictors and Management of Patients who Failed Fecal Microbiota Transplantation for Recurrent C. difficile Infection
40. Microscopic Polyangiitis Masquerading as Pancreatitis
41. Increasing In vitro Clostridium difficile Antibiotic Resistance: A Systematic Review 2017 Presidential Poster Award
42. Optimization of a Scoring System to Predict Microscopic Colitis in a Cohort of Patients With Chronic Diarrhea
43. Fecal microbiota transplantation for gastrointestinal disorders
44. Diagnosis and Management of Microscopic Colitis
45. New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation
46. Chronic unexplained diarrhea
47. Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography
48. Clinical Features and Treatment Responses in Pediatric Lymphocytic and Collagenous Colitis
49. Acute Kidney Injury is an Independent Marker of Severity in Clostridium difficile Infection
50. Appendectomy Is Not Associated With Adverse Outcomes in Clostridium difficile Infection: A Population-Based Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.